拜耳利伐沙班使用说明
Rivaroxaban is a new type of oral anticoagulant that can directly inactivate factor
Bayer Healthcare is a leading global innovative pharmaceutical company dedicated to developing, producing and marketing innovative products that improve human health. These products improve people's overall health and quality of life through the diagnosis, prevention and treatment of diseases, including Rivaroxaban.
Instructions for use of Bayer's Rivaroxaban: Under normal circumstances, the recommended dose of Rivaroxaban is 10 mg/time, once/day, and the medication is taken orally. When the wound has stopped bleeding, the patient's first medication should be administered between 6 and 10 hours after surgery. If the patient misses a dose during this period, the patient should take rivaroxaban (Xarelto) immediately and continue the previous usage the next day, that is, take the medication once a day. When actually taking the drug, patients can take it with meals or alone.
From the perspective of pharmacokinetics and pharmacodynamics, rivaroxaban can be rapidly absorbed in healthy people, with peak concentrations reaching the highest levels 2 to 4 hours after a single dose of 1.25-80 mg or multiple doses. Studies have shown that the activity of factor Xa is inhibited in a dose-dependent manner. The strongest inhibition time is 1-4 hours after administration. When a single dose of 5-80 mg is taken, the maximum inhibition rate is 20% to 61%. After multiple doses per day, there is no significant difference in the maximum inhibition of factor Xa activity.
Recommended hot articles: /newsDetail/96961.html
Note: The above information comes from the Internet and is compiled and edited by Medical Companion Travel (please correct me if there are any errors or omissions). It is only to provide information on the latest drugs on the market in the world and help Chinese patients understand the latest international new drug trends. It is only for internal discussion among medical staff and does not serve as any basis for medication. For specific medication guidelines, please consult the attending physician.
[ 免责声明 ] 本页面内容来自公开渠道(如FDA官网、Drugs官网、原研药厂官网等),仅供持有医疗专业资质的人员用于医学药学研究参考,不构成任何治疗建议或药品推荐。所涉药品可能未在中国大陆获批上市,不适用于中国境内销售和使用。如需治疗,请咨询正规医疗机构。本站不提供药品销售或代购服务。
.jpeg)